J&J, Merck CEOs dodge subpoenas by agreeing to testify at Senate committee's pricing hearing
J&J, Merck CEOs dodge subpoenas by agreeing to testify at Senate committee's pricing hearing fkansteiner Fri, 01/26/2024 - 15:40
J&J, Merck CEOs dodge subpoenas by agreeing to testify at Senate committee's pricing hearing fkansteiner Fri, 01/26/2024 - 15:40
Lonza closes plant in China but CDMO's sales signal an uptick in industry kdunleavy Fri, 01/26/2024 - 14:55
Merck's Keytruda extends life for kidney cancer patients after surgery, while Bristol's Opdivo fails again aliu Fri, 01/26/2024 - 14:41
Bristol Myers wins, Apellis loses in busy week at Europe's drug regulator kdunleavy Fri, 01/26/2024 - 10:23
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer aliu Fri, 01/26/2024 - 10:02
‘The Top Line’: Closing the $1 trillion women’s health gap aellison Fri, 01/26/2024 - 09:55
AbbVie pumps $223M into Singapore biologics plant, plots 100 hires fkansteiner Fri, 01/26/2024 - 08:40
Drug mix-up prompts Azurity to recall 1 batch of narcolepsy drug Zenzedi esagonowsky Fri, 01/26/2024 - 08:38
Sanofi and Regeneron's Dupixent picks up FDA nod to treat kids with eosinophilic esophagitis kdunleavy Fri, 01/26/2024 - 07:29
PTC's re-examination bid for DMD drug Translarna falls short in Europe esagonowsky Thu, 01/25/2024 - 17:10
Fierce Pharma Asia—Carvykti faces FDA adcomm; AZ drug picks up world-first approval; Samsung Bio's year of growth aliu Thu, 01/25/2024 - 16:55